Research Grade Anti-Human CD269/TNFRSF17/BCMA Antibody (SEA-BCMA)Anti-Human CD269/TNFRSF17/BCMA Antibody (SEA-BCMA) ( HX959206 ) is a research-grade recombinant antibody targeting CD269 . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns. Спецификация| Species reactivity | Human | | Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo | | Form | Liquid | | Storage | -20℃ | | Product category | Biosimilar | | Target | Tumor necrosis factor receptor superfamily member 17, TNFRSF17, CD269, B-cell maturation protein, BCMA, BCM | | Accession | Q02223 | | Host species | Human | | | |
Информация для заказа| Область использования: | Производство: | Puda Scientific | | Метод: | Иммуногистохимия | | Объем: | 1mg | | Кат. номер: | PD-A26-521-100 | | Цена (с НДС 22%): | по запросу | В корзину  | Наименование: Research Grade Anti-Human CD269/TNFRSF17/BCMA Antibody (SEA-BCMA).
Примечание: |
|
